Newsroom

When statistical sciences were in their infancy, the communicative benefits of statistics were widely touted. Thousands..

In recent times, Single arm trials are being increasingly used to assess new treatment interventions. They establish..

The past decade has witnessed the rise of simulations-based clinical trial optimization in a manner unimaginable to..

As the use of master protocols becomes more prevalent in drug development, Bayesian methods are extensively used to..

Historically, advances in the statistical design of clinical trials have accompanied progress within the science and..

2020 has been an unusually difficult year as the global pandemic impacted all of our lives. This year, the Cytel blog..

As Chief Scientific Officer, Dr. Yannis Jemiai plays a pivotal role in maintaining Cytel’s well-established reputation..

When designing clinical trials, biostatisticians and clinical development teams are often faced with a conundrum. Given..

  As a part of Cytel’s Advanced Design Framework, a new Framework for the statistical design of clinical trials, Cytel..